CBER Director Peter Marks (Greg Nash/Pool via AP Images)

Marks re­hash­es Covid-19 ap­proval time­line, de­fends vac­cines for chil­dren at hear­ing

FDA’s Pe­ter Marks ap­peared be­fore a House pan­el on Thurs­day to field ques­tions on how to im­prove the na­tion’s vac­cine safe­ty sys­tems in the event of an­oth­er pub­lic health emer­gency. He didn’t make it out with­out get­ting caught in the po­lit­i­cal cross­fire over vac­cine mis­in­for­ma­tion.

Marks, who leads the agency’s Cen­ter for Bi­o­log­ics Eval­u­a­tion and Re­search, tes­ti­fied be­fore the House Over­sight Com­mit­tee’s coro­n­avirus se­lect sub­com­mit­tee. Dur­ing his tes­ti­mo­ny, he high­light­ed chal­lenges that the FDA faced in get­ting re­al-time vac­cine safe­ty da­ta through­out the pan­dem­ic.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.